A Dose-by-Dose Tracker of GLP-1 Shortage Status
Shortage status for GLP-1 drugs isn't all-or-nothing — it's tracked by specific dose strength, and different strengths of the same drug can have different availability.
By the GLP Semaglutide editorial team · Last updated June 15, 2025
The FDA's shortage database lists availability by specific National Drug Code (NDC), which typically corresponds to a specific dose strength and pen configuration — meaning a lower starting dose might be listed as available while a higher maintenance dose is listed as short, or vice versa.
Why this granularity matters
Patients starting titration and patients on a stable maintenance dose can have very different experiences with availability at the same time, which is easy to miss in headline-level reporting that describes a drug as simply 'in shortage' or 'resolved.'
How to check your specific dose
Searching the FDA shortage database by drug name will show current status broken out by strength and package size — the most reliable way to know whether your specific prescription is affected.
Primary sources